Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

Press releases published on August 14, 2026

2 hours ago

Bond Provides Business Update and Reports 2026 Second Quarter Financial Results

Indeterminate GlobeNewswire

2 hours ago

Nexera: Subsidiary Fort Technology Reports Record First Half of 2026 Results with 49% Revenue Growth to $7.36 Million and 145% Increase in Gross Profit Year over Year and Expanding to Solutions for Data Centers

Indeterminate GlobeNewswire

2 hours ago

Trident Digital Tech Joint Venture Projects Sikaflow Revenue Run-Rate of Approximately US$65 Million Annualized Exiting 2026

Indeterminate GlobeNewswire

2 hours ago

Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026

Indeterminate GlobeNewswire

2 hours ago

PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

2 hours ago

GT Biopharma Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease

Indeterminate GlobeNewswire

2 hours ago

CSPi Reports FY2026 Third Quarter Results

Indeterminate GlobeNewswire

2 hours ago

Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

2 hours ago

Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

2 hours ago

How Appinventiv is Solving AI Adoption Challenges for Global Enterprises

Indeterminate GlobeNewswire

3 hours ago

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

Indeterminate GlobeNewswire

3 hours ago

Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks

Indeterminate GlobeNewswire

3 hours ago

WRAP Selected by WOFT to Support Florida’s $475,000 Teacher Safety Training Initiative

Indeterminate GlobeNewswire

3 hours ago

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Indeterminate GlobeNewswire

3 hours ago

Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

3 hours ago

Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 

Indeterminate GlobeNewswire

3 hours ago

 Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Indeterminate GlobeNewswire

3 hours ago

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Indeterminate GlobeNewswire